Moolec Science Statistics
Total Valuation
Moolec Science has a market cap or net worth of $33.80 million. The enterprise value is $53.62 million.
Important Dates
The last earnings date was Wednesday, October 2, 2024, before market open.
| Earnings Date | Oct 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Moolec Science has 37.56 million shares outstanding. The number of shares has increased by 11.66% in one year.
| Shares Outstanding | 37.56M |
| Shares Change (YoY) | +11.66% |
| Shares Change (QoQ) | -4.10% |
| Owned by Insiders (%) | 16.32% |
| Owned by Institutions (%) | 0.41% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.16 |
| Forward PS | 5.41 |
| PB Ratio | 4.78 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.69
| Current Ratio | 1.69 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.76 |
Financial Efficiency
Return on equity (ROE) is -86.42% and return on invested capital (ROIC) is -57.77%.
| Return on Equity (ROE) | -86.42% |
| Return on Assets (ROA) | -19.21% |
| Return on Capital (ROIC) | -57.77% |
| Revenue Per Employee | $125,002 |
| Profits Per Employee | -$162,493 |
| Employee Count | 45 |
| Asset Turnover | 0.19 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.05M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.98% in the last 52 weeks. The beta is -0.54, so Moolec Science's price volatility has been lower than the market average.
| Beta (5Y) | -0.54 |
| 52-Week Price Change | -67.98% |
| 50-Day Moving Average | 0.88 |
| 200-Day Moving Average | 1.34 |
| Relative Strength Index (RSI) | 53.10 |
| Average Volume (20 Days) | 16,186 |
Short Selling Information
The latest short interest is 140,780, so 0.37% of the outstanding shares have been sold short.
| Short Interest | 140,780 |
| Short Previous Month | 142,628 |
| Short % of Shares Out | 0.37% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.65 |
Income Statement
In the last 12 months, Moolec Science had revenue of $5.63 million and -$7.31 million in losses. Loss per share was -$0.19.
| Revenue | 5.63M |
| Gross Profit | 472,600 |
| Operating Income | -9.04M |
| Pretax Income | -8.08M |
| Net Income | -7.31M |
| EBITDA | -8.18M |
| EBIT | -9.04M |
| Loss Per Share | -$0.19 |
Full Income StatementBalance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 6.82M |
| Book Value Per Share | 0.19 |
| Working Capital | 5.60M |
Full Balance SheetCash Flow
| Operating Cash Flow | -9.33M |
| Capital Expenditures | n/a |
| Free Cash Flow | -9.33M |
| FCF Per Share | -$0.25 |
Full Cash Flow StatementMargins
Gross margin is 8.40%, with operating and profit margins of -160.76% and -129.99%.
| Gross Margin | 8.40% |
| Operating Margin | -160.76% |
| Pretax Margin | -148.61% |
| Profit Margin | -129.99% |
| EBITDA Margin | -145.45% |
| EBIT Margin | -160.76% |
| FCF Margin | -221.53% |